$4.52-0.08 (-1.74%)
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally.
EDAP TMS S.A. in the Healthcare sector is trading at $4.52 with a market capitalization of $169M. Wall Street consensus targets $5.83 (3 analysts), implying a +29.1% move over the next 12 months. The stock is currently near its 52-week high of $5.05, remaining 39.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $17.81M↓ | $51.61M↑ | $16.28M↓ | $18.81M↑ | $14.27M |
| Gross Profit | $8.15M↓ | $21.86M↑ | $7.01M↓ | $8.00M↑ | $5.99M |
| Operating Income | -$7.37M↑ | -$17.98M↓ | -$5.78M↑ | -$6.76M↓ | -$6.31M |
| Net Income | -$9.08M↑ | -$22.41M↓ | -$5.88M↑ | -$6.57M↑ | -$7.44M |
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company o...